Lerer I - Search Results

1

Cystic fibrosis mutations delta F508 and G542X in Jewish patients.

Lerer I, Sagi M, Cutting GR, Abeliovich D. Lerer I, et al. J Med Genet. 1992 Feb;29(2):131-3. doi: 10.1136/jmg.29.2.131. J Med Genet. 1992. PMID: 1377276 Free PMC article.

2

Prevalence of myotonic dystrophy in Israeli Jewish communities: inter-community variation and founder premutations.

Segel R, Silverstein S, Lerer I, Kahana E, Meir R, Sagi M, Zilber N, Korczyn AD, Shapira Y, Argov Z, Abeliovich D. Segel R, et al. Among authors: lerer i. Am J Med Genet A. 2003 Jun 15;119A(3):273-8. doi: 10.1002/ajmg.a.20177. Am J Med Genet A. 2003. PMID: 12784291

3

Mutation spectrum in Jewish cystic fibrosis patients in Israel: implication to carrier screening.

Quint A, Lerer I, Sagi M, Abeliovich D. Quint A, et al. Among authors: lerer i. Am J Med Genet A. 2005 Jul 30;136(3):246-8. doi: 10.1002/ajmg.a.30823. Am J Med Genet A. 2005. PMID: 15948195

4

Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.

Cutting GR, Curristin SM, Nash E, Rosenstein BJ, Lerer I, Abeliovich D, Hill A, Graham C. Cutting GR, et al. Among authors: lerer i. Am J Hum Genet. 1992 Jun;50(6):1185-94. Am J Hum Genet. 1992. PMID: 1376017 Free PMC article.

5

Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.

Abeliovich D, Lavon IP, Lerer I, Cohen T, Springer C, Avital A, Cutting GR. Abeliovich D, et al. Among authors: lerer i. Am J Hum Genet. 1992 Nov;51(5):951-6. Am J Hum Genet. 1992. PMID: 1384328 Free PMC article.

6

The delta F508 mutation in Israeli CF families.

Lerer I, Cohen S, Chemke M, Friedmen A, Abeliovich D. Lerer I, et al. Adv Exp Med Biol. 1991;290:365-6. Adv Exp Med Biol. 1991. PMID: 1950748 No abstract available.

7

The frequency of the delta F508 mutation on cystic fibrosis chromosomes in Israeli families: correlation to CF haplotypes in Jewish communities and Arabs.

Lerer I, Cohen S, Chemke M, Sanilevich A, Rivlin J, Golan A, Yahav J, Friedman A, Abeliovich D. Lerer I, et al. Hum Genet. 1990 Sep;85(4):416-7. doi: 10.1007/BF02428288. Hum Genet. 1990. PMID: 1976595

8

Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool.

Elyakim S, Lerer I, Zlotogora J, Sagi M, Gelman-Kohan Z, Merin S, Abeliovich D. Elyakim S, et al. Among authors: lerer i. Am J Med Genet. 1994 Dec 1;53(4):325-34. doi: 10.1002/ajmg.1320530405. Am J Med Genet. 1994. PMID: 7864041

9

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T. Abeliovich D, et al. Among authors: lerer i. Am J Hum Genet. 1997 Mar;60(3):505-14. Am J Hum Genet. 1997. PMID: 9042909 Free PMC article.

10

Cystic fibrosis heterozygote screening in the Orthodox Community of Ashkenazi Jews: the Dor Yesharim approach and heterozygote frequency.

Abeliovich D, Quint A, Weinberg N, Verchezon G, Lerer I, Ekstein J, Rubinstein E. Abeliovich D, et al. Among authors: lerer i. Eur J Hum Genet. 1996;4(6):338-41. doi: 10.1159/000472229. Eur J Hum Genet. 1996. PMID: 9043867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters